LexaGene unveiled the LX2 prototype design to a veterinary diagnostics audience on October 20th, 2018 at the AAVLD Annual Meeting in Kansas City. LX2 Prototype design; Unveiling at Booth 203 by CEO Dr. Jack Regan; Veterinary diagnosticians engaging with LX2 technology.
See how rapid, point-of-care molecular diagnostics could have improved patient outcome. Read the story of how Nancy the Dachshund did not receive the correct treatment due to the lag-time to receive lab results, and how LexaGene’s LX6 could have prevented this scenario.
LexaGene describes the technology behind our fully automated, open-access pathogen detection device, the LX Analyzer.
Imagine anyone collecting a raw sample, loading it onto a fully automated instrument and getting a genetic result in about 1 hour.
These annotated images show the basics of how our technology works. The LX6 is the first automated pathogen detection system of its kind.
At a conference in July 2017, LexaGene unveiled our LX6 alpha prototype to get early feedback from the food safety market.